Cargando…

Highly purified human-derived follicle-stimulating hormone (Bravelle®) has equivalent efficacy to follitropin-beta (Follistim ®) in infertile women undergoing in vitro fertilization

BACKGROUND: These data compare the efficacy and safety of highly purified human-derived follicle-stimulating hormone (Bravelle(R)) and recombinant follitropin-β (Follistim(R)) in women undergoing in vitro fertilization. METHODS: This report describes the pooled data from two, nearly identical, rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dickey, Richard P, Nichols, John E, Steinkampf, Michael P, Gocial, Benjamin, Thornton, Melvin, Webster, Bobby W, Bello, Sandra M, Crain, Jack, Marshall, Dennis C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270000/ https://www.ncbi.nlm.nih.gov/pubmed/14609434 http://dx.doi.org/10.1186/1477-7827-1-63

Ejemplares similares

Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe
por: Scobey, M Joseph, et al.
Publicado: (2005)

Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
por: Bühler, Klaus
Publicado: (2015)

A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro
por: Azzam, Naiel, et al.
Publicado: (2021)

A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
por: Esteves, Sandro C, et al.
Publicado: (2009)

Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization
por: Keye, William R, et al.
Publicado: (2005)

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
por: Gizzo, Salvatore, et al.
Publicado: (2016)

A redesigned follitropin alfa pen injector for infertility: results of a market research study
por: Abbotts, Carole, et al.
Publicado: (2011)

In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta
por: Haakman, Olga, et al.
Publicado: (2020)

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency
por: Rinaldi, Leonardo, et al.
Publicado: (2016)

Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET
por: Kang, Hyuk-Jae, et al.
Publicado: (2011)

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
por: Patel, Nayana Hitesh, et al.
Publicado: (2023)

Recombinant follitropin alfa/lutropin alfa in fertility treatment
por: Gibreel, Ahmed, et al.
Publicado: (2010)

Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
Publicado: (2023)

Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
por: Kaplan, Sigal, et al.
Publicado: (2021)

Quantitative measurement of melanin as tyrosine equivalents and as weight of purified melanin.
por: Oikawa, A., et al.
Publicado: (1973)

Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development
por: Abramova, Nadezda, et al.
Publicado: (2018)

Glycosylation Pattern and in vitro Bioactivity of Reference Follitropin alfa and Biosimilars
por: Riccetti, Laura, et al.
Publicado: (2019)

Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions
por: Manzi, Lucio, et al.
Publicado: (2022)

Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
por: Illingworth, Peter J, et al.
Publicado: (2014)

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015)

Ovulation induction with minimal dose of follitropin alfa: a case series study
por: Bruna-Catalán, Isidoro, et al.
Publicado: (2011)

In Vitro Effects of the Endocrine Disruptor p,p’-DDT on Human Follitropin Receptor
por: Munier, Mathilde, et al.
Publicado: (2016)

Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
por: Shao, Feng, et al.
Publicado: (2022)

The Effect of Follitropin Alfa in Controlled Ovarian Stimulation Protocol for In Vitro Fertilization Cycles
por: Prasetiawati, Novita, et al.
Publicado: (2023)

Comparison of Manual and Automated Measurements of Monodominant Follicle Diameter with Different Follicle Size in Infertile Patients
por: Pan, Ping, et al.
Publicado: (2013)

Human factors engineering and design validation for the redesigned follitropin alfa pen injection device
por: Mahony, Mary C, et al.
Publicado: (2015)

Human hair follicle equivalents in vitro for transplantation and chip-based substance testing
por: Horland, R, et al.
Publicado: (2011)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment
por: Agostinetto, Rita
Publicado: (2009)

Influence of the Hinge Region and Its Adjacent Domains on Binding and Signaling Patterns of the Thyrotropin and Follitropin Receptor
por: Schaarschmidt, Jörg, et al.
Publicado: (2014)

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
por: Xue, Weiguang, et al.
Publicado: (2019)

Review on Autoimmune Reactions in Female Infertility: Antibodies to Follicle Stimulating Hormone
por: Haller-Kikkatalo, Kadri, et al.
Publicado: (2012)

Antral follicle count in normal (fertility-proven) and infertile Indian women
por: Agarwal, Arjit, et al.
Publicado: (2014)

Abnormally Elevated Follicle-Stimulating Hormone (FSH) Level in an Infertile Woman
por: Catteau, Aurore, et al.
Publicado: (2019)

Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting
por: Griesinger, Georg, et al.
Publicado: (2021)

The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women
por: Barbakadze, Ludmila, et al.
Publicado: (2015)

Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
por: Strowitzki, Thomas, et al.
Publicado: (2016)

The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
por: Gleicher, Norbert, et al.
Publicado: (2011)

Prematurely ruptured dominant follicles often retain competent oocytes in infertile women
por: Teramoto, S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gtek66gno7p46ad4c55985moef